98%
921
2 minutes
20
Formulation and manufacturing of push-pull osmotic pump (PPOP) tablets are perceived to be complex technological processes. Multiple factors affect drug release kinetics, including polymer grade, drug-to-osmotic agent ratio, membrane characteristics, and manufacturing methods. In this study, we comprehensively investigated how manufacturing techniques impacted glipizide PPOP tablet performance. PPOP tablets comprised push and drug layers manufactured via wet granulation and/or direct compression methods, and different grades of poly(ethylene oxide) (molecular weights 5000 kDa and 4000 kDa) were used in the push layer. Tablets were characterized using biopredictive dissolution tests in the Advanced Modular Platform (AMP) apparatus under both fasted and fed conditions, simulating physiologically relevant mechanical stress events. Magnetic resonance imaging (MRI) was employed to noninvasively monitor tablet hydration, swelling dynamics, and water distribution in the PPOP during hydration. Physiologically based biopharmaceutics modeling (PBBM) was used to simulate glipizide plasma concentrations. All manufactured PPOP tablets released glipizide similarly, following zero-order kinetics, regardless of the manufacturing method and polymer grade in the push layer. Push and drug layer swelling patterns were also comparable. Under simulated mechanical stress conditions, even those exceeding physiological values, all batches maintained consistent release profiles without dose dumping. Only one batch, with both layers directly compressed, showed slightly slower release under fed conditions, but the PBBM model showed a limited influence on the predicted glipizide plasma concentrations. In conclusion, the manufacturing method and polymer grade had minimal impact on PPOP tablet performance, with direct compression providing a viable alternative to wet granulation. PPOP tablets demonstrated robust resistance to physiologically relevant mechanical stress, confirming their prominent role as controlled drug delivery systems.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.molpharmaceut.5c00612 | DOI Listing |
Mol Pharm
September 2025
Physiolution, 74 Piłsudskiego St, Wrocław 50-020, Poland.
Formulation and manufacturing of push-pull osmotic pump (PPOP) tablets are perceived to be complex technological processes. Multiple factors affect drug release kinetics, including polymer grade, drug-to-osmotic agent ratio, membrane characteristics, and manufacturing methods. In this study, we comprehensively investigated how manufacturing techniques impacted glipizide PPOP tablet performance.
View Article and Find Full Text PDFDrugs R D
June 2025
Medical Support Center, General Hospital of Central Theater Command, Wuhan, 430070, China.
Background And Objective: Ketorolac tromethamine (KT), a nonsteroidal anti-inflammatory drug (NSAID) and cyclooxygenase inhibitor, is commonly used for the management of moderate to severe pain. The objective of this study was to compare the pharmacokinetic characteristics of KT in beagle dogs following oral administration of conventional tablets and a novel tablet-in-tablet (TIT) formulation.
Methods: A comparative dissolution study was conducted to evaluate the release profiles of both formulations.
Sci Rep
March 2025
Department of Pharmaceutics & Bioavailability and Bioequivalence Research Facility, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Karachi, 75270, Pakistan.
The study is based on applying Artificial Neural Network (ANN) based machine learning and Response Surface Methodology (RSM) as simultaneous bivariate approaches in developing controlled-release rivaroxaban (RVX) osmotic tablets. The influence of different types of polyethylene oxide, osmotic agents, coating membrane thickness, and orifice diameter on RVX release profiles was investigated. After obtaining the trial formulation data sets from Central Composite Design (CCD), an ANN-based model was trained to get the optimized formulations.
View Article and Find Full Text PDFPharm Dev Technol
February 2025
Medical support center, General Hospital of Central Theater Command of the PLA, Wuhan, China.
The aim of this study was to develop and evaluate an extended-release (ER) push-pull osmotic pump (PPOP) tablet for phencynonate HCl (PCN), which could release the drug at zero-order profile for a duration of 24 h. The core tablets were designed as bi-layered, primarily composed of sodium chloride and polyethylene oxide (PEO). The central composite design (CCD) within a response surface methodology (RSM) was used to optimize the formulation.
View Article and Find Full Text PDFPLoS One
March 2022
Department of Pharmacy, General Hospital of Central Theater of the PLA, Wuhan, Hubei, China.
Topiramate (TPM) was an antiepileptic agent commonly used in clinical. Studies showed that an oral preparation of TPM with extended-release manner could bring some benefits for epileptics. In this paper, controlled release push-pull osmotic pump (PPOP) tablets of sparingly water-soluble TPM were successfully prepared.
View Article and Find Full Text PDF